Hormone Dependent Cancers: Mechanisms and Biomarkers

OR23-1

Mechanism and Disruption of Androgen Receptor Variant Enhancement By Its Co-Activator Vav3: A Novel Targeted Approach for Prostate Cancer
Fiorella Magani, Stephanie O. Peacock, Pablo Sebastian Magani, Jonathan R. Weitz and Kerry L Burnstein

OR23-2

Intraductal Carcinoma of the Prostate: A Malignant Lesion That Evades Androgen Deprivation Therapy
Laura H Porter, Mitchell G Lawrence, Kohei Hashimoto, Hong Wang, Melissa Papargiris, Heather Thorne, , kConFab, Mark Frydenberg, Declan Murphy, Andrew Ryan, David Clouston, Damien Bolton, Carmel Pezaro, Gail P Risbridger and Renea A Taylor

OR23-3

High-Throughput Identification of Androgen Signalling-Modulatory Micrornas in Prostate Cancer Reveals New Oncomirs and Drug Targets
Claire E Fletcher, Ailsa Sita-Lumsden, Alwyn Dart, Eric Sulpice, Stephanie Combe, Laurent Guyon, Johann de Bono, Xavier Gidrol and Charlotte Lynne Bevan

OR23-5

EZH2 Is a Key Player in Progestin-Induced Breast Cancer Growth and Tamoxifen Resistance
Mauro Ezequiel Cenciarini, Juan Cruz Gomez Poviña, María Florencia Mercogliano, Noelia Paula Di Giorgio, Roxana Schillaci, Patricia Virginia Elizalde, Franco Izzo and Cecilia Jazmín Proietti